Therefore, our study demonstrates that the PVT1/ HIF2α positive feedback loop involves in tumorigenesis and progression of ccRCC, which may be exploited for anticancer therapy. This evidence concerns the gene EPAS1 and nonpapillary renal cell carcinoma.